BERKELEY, Calif.--(BUSINESS WIRE)--March 8, 2006--XOMA Ltd. (NASDAQ:XOMA), a leader in the discovery and development of antibody therapeutics for cancer and immunological disorders, today announced its results for the quarter and full year ended December 31, 2005.
